HomeInsightsStock Comparison

Genomic Valley Biotech Ltd vs Innokaiz India Ltd Stock Comparison

Genomic Valley Biotech Ltd vs Innokaiz India Ltd Stock Comparison

Last Updated on: Mar 16, 2026

Key Highlights

  • The Latest Trading Price of Genomic Valley Biotech Ltd is ₹ 28.43 as of 16 Mar 15:30 . The P/E Ratio of Genomic Valley Biotech Ltd changed from 694.2 on March 2024 to 50.1 on March 2025 . This represents a CAGR of -73.14% over 2 yearsThe P/E Ratio of Innokaiz India Ltd changed from 25.3 on March 2024 to 0 on March 2025 . This represents a CAGR of -100.00% over 2 years The Market Cap of Genomic Valley Biotech Ltd changed from ₹ 10.6 crore on March 2024 to ₹ 17.9 crore on March 2025 . This represents a CAGR of 29.95% over 2 yearsThe Market Cap of Innokaiz India Ltd changed from ₹ 53.37 crore on March 2024 to ₹ 13.15 crore on March 2025 . This represents a CAGR of -50.36% over 2 years The revenue of Genomic Valley Biotech Ltd for the Dec '25 is ₹ 0.05 crore as compare to the Sep '25 revenue of ₹ 0.09 crore. This represent the decline of -44.44% The revenue of Innokaiz India Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Genomic Valley Biotech Ltd for the Dec '25 is ₹ 0.01 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the growth of 9.2233718E16% The ebitda of Innokaiz India Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Genomic Valley Biotech Ltd changed from ₹ 0.13 crore to ₹ 0.01 crore over 7 quarters. This represents a CAGR of -76.91% The net profit of Innokaiz India Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The Dividend Payout of Genomic Valley Biotech Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Innokaiz India Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Genomic Valley Biotech Ltd

  • Incorporated in May 1994, Genomic Valley Biotech Limited is formed with the objective of conducting research in the field of Biotechnology (Plant & Animal) and also to undertake commercial production of Plant Tissue Cultured Plants of different species to feed the genetically improved plant market nationally as well as internationally.
  • The Company is extensively involved in commercial greenhouse / poly house cultivation of crops.
  • Presently, it is engaged in high-tech cultivation through environmental controlled Poly Houses,NFT & DFT etc,manufacturing of Tissue Cultured Improved variety of plants and organic farming using Bio-Fertilizer.
  • Also it is involved in commercial Horticulture activities with Aloe vera, Tomato, Bitter Gourd, Bottle Gourd, Brinjal, Broccoli, Cabbage, Capsicum, Carrot, Cauliflower, Cucumber, Green Chillies, Onion, Radish, Ridge/Sponge Gourd, Leafy Vegetables, Pumpkin, Banana, Guava, Papaya, and Strawberry.

About Innokaiz India Ltd

  • Innokaiz India Limited was originally incorporated on January 11, 2013 as a Private Company with the Registrar of Companies, Chennai.
  • Subsequently, Company was converted to Public Limited Company and a Fresh Certificate of Incorporation was issued on September 27, 2022. Promoted by Mr. Balakrishnan Sukumarbalakrishnan, Innokaiz India is a corporate services and solutions provider Company, which emerged as are a one stop solution provider for various corporate needs.
  • Company is a pioneering leader in marketing and promotional solutions, in transforming brands and businesses across India through innovative strategies and impactful services.
  • Specializing in Outdoor Ads & Signage, Event / MICE / R & R, Corporate Gifts, Promotional Products, Trophies / Momentoes, Badges / Medals / Certificates, ATL, BTL & Activations, and Online Advertising, Innokaiz excels in delivering customized solutions that enhance brand visibility and engagement.

FAQs for the comparison of Genomic Valley Biotech Ltd and Innokaiz India Ltd

Which company has a larger market capitalization, Genomic Valley Biotech Ltd or Innokaiz India Ltd?

Market cap of Genomic Valley Biotech Ltd is 7 Cr while Market cap of Innokaiz India Ltd is 11 Cr

What are the key factors driving the stock performance of Genomic Valley Biotech Ltd and Innokaiz India Ltd?

The stock performance of Genomic Valley Biotech Ltd and Innokaiz India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Genomic Valley Biotech Ltd and Innokaiz India Ltd?

As of March 16, 2026, the Genomic Valley Biotech Ltd stock price is INR ₹24.99. On the other hand, Innokaiz India Ltd stock price is INR ₹11.55.

How do dividend payouts of Genomic Valley Biotech Ltd and Innokaiz India Ltd compare?

To compare the dividend payouts of Genomic Valley Biotech Ltd and Innokaiz India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions